Evidence map›Paper›PMID 37637186›Full record

ArticleIntegrative medicine research2023

Clinical effectiveness of decoction form of herbal medicine in primary care treatment of allergic rhinitis: A retrospective cohort study.

Mi Ju Son, Sungha Kim, Young-Eun Kim, Bo-Young Kim, Chang-Sub Yeum, Jong Cheol Lee, Jae Hoon Cha, Soonsik Kang, Ching Hao Chang, Seokho Son

Open access · goldAbstract read
In one paragraph

Article in Integrative medicine research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Targeting triple-negative breast cancer: apoptotic and antitumor effects of Artemisia sieberi Besser extracts.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mi Ju SonR&D Planning Team, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
Sungha KimKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
Young-Eun KimKM Data Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
Bo-Young KimKM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.
Chang-Sub YeumSNB Korean Medicine Clinic, Seoul, Republic of Korea.
Jong Cheol Lee365 Cha Korean Medicine Clinic, Yeosu, Republic of Korea.
Jae Hoon Cha365 Cha Korean Medicine Clinic, Yeosu, Republic of Korea.
Soonsik KangMoa Korean Medicine Clinic, Seoul, Republic of Korea.
Ching Hao ChangMoa Korean Medicine Clinic, Wonju, Republic of Korea.
Seokho SonI-Bone Korean Medicine Clinic, Asan, Republic of Korea.
Dunsan Korean Medicine Hospital · KRKorea Institute of Oriental Medicine · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The decoction form of herbal medicine (D-HM) is mainly prescribed to patients with allergic rhinitis (AR) in Korean Medicine (KM) clinics in the Republic of Korea; however, it is difficult to conduct clinical trials of D-HM due to regulatory issues. This study investigated the clinical safety and effectiveness of D-HM combination therapy for the treatment of AR by analyzing the AR outpatient data from 17 KM clinics. Methods: This retrospective cohort study included patients who visited KM clinics for AR treatment from January 1, 2021, to March 31, 2022. Cases were collated using structured case report forms and divided into the D-HM with KM usual care group (D-HM group) and the KM usual care group (UC group). Since D-HM therapy could not be randomly assigned to the study population, we used optimal propensity score (PS) matching to investigate the effectiveness and safety of D-HM combination therapy in the treatment of AR. Results: Data from 228 patients were collected. After PS matching, 144 patients were finally analyzed. The total nasal symptom score (TNSS) and mini-rhinoconjunctivitis quality of life questionnaire (mini-RQLQ) were significantly improved in the D-HM group compared with those in the UC group (TNSS: p=0.02; mini-RQLQ: p=0.04). Four patients in the D-HM group experienced minor adverse events that were mild and resolved within 15 days. Conclusions: D-HM combination therapy may be beneficial in the management of symptoms and rhinitis-associated quality of life and potentially useful in clinical practice. However, randomized placebo-controlled clinical trials are required to confirm their effectiveness. Study registration: This study has been registered at Clinical Research Information Service (KCT0007242).

Indexed as

Allergic rhinitisHerbal medicinePropensity score matchingRetrospective cohort study

Identifiers

PMID37637186
PMCPMC10448014
OpenAlexW4384007214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.